GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » 6-1 Month Momentum %

Genomma Lab InternacionalB de CV (MEX:LABB) 6-1 Month Momentum % : 21.02% (As of Jun. 25, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-06-25), Genomma Lab InternacionalB de CV's 6-1 Month Momentum % is 21.02%.

The industry rank for Genomma Lab InternacionalB de CV's 6-1 Month Momentum % or its related term are showing as below:

MEX:LABB's 6-1 Month Momentum % is ranked better than
77.8% of 1117 companies
in the Drug Manufacturers industry
Industry Median: -3.45 vs MEX:LABB: 21.02

Competitive Comparison of Genomma Lab InternacionalB de CV's 6-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV's 6-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's 6-1 Month Momentum % falls into.



Genomma Lab InternacionalB de CV  (MEX:LABB) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomma Lab InternacionalB de CV  (MEX:LABB) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Genomma Lab InternacionalB de CV 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV (MEX:LABB) Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovalí Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV (MEX:LABB) Headlines

No Headlines